Clinical and Imaging Progression in the PARS Cohort: Long‐Term Follow‐up

Background and Objectives The PARS (Parkinson Associated Risk Syndrome) study was designed to test whether screening for hyposmia followed by dopamine transporter imaging can identify risk for conversion to clinical PD, and to evaluate progression markers during the prodromal period. Methods Subject...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Movement disorders 2020-09, Vol.35 (9), p.1550-1557
Hauptverfasser:	Siderowf, Andrew, Jennings, Danna, Stern, Matthew, Seibyl, John, Eberly, Shirley, Oakes, David, Marek, Kenneth, Marek, Ken, Russell, David, Sethi, Kapil, Frank, Samuel, Simuni, Tanya, Hauser, Robert, Ravina, Bernard, Richards, Irene, Liang, Grace, Adler, Charles, Saunders‐Pullman, Rachel, Evatt, Marian L., Lai, Eugene, Subramanian, Indu, Hogarth, Penelope, Chung, Kathryn
Format:	Artikel
Sprache:	eng
Schlagworte:	biomarkers Cohort Studies Computed tomography Dopamine Dopamine Plasma Membrane Transport Proteins Dopamine transporter dopamine transporter imaging Follow-Up Studies Humans Movement disorders Neurodegenerative diseases Olfaction disorders Parkinson Disease - diagnostic imaging Parkinson's disease prodromal Prodromal Symptoms Survival analysis Tomography, Emission-Computed, Single-Photon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!